UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
SCHEDULE l3D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
KINDRED HEALTHCARE, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.25 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
494580103
--------------------------------------------------------------------------------
(CUSIP Number)
with a copy to:
Stephen Feinberg Robert G. Minion, Esq.
450 Park Avenue Lowenstein Sandler PC
28th Floor 65 Livingston Avenue
New York, New York 10022 Roseland, New Jersey 07068
(212) 421-2600 (973) 597-2424
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 22, 2003
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule l3G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Cusip No. 494580103
--------------------------------------------------------------------------------
1) Names of Reporting Persons. I.R.S. Identification Nos. of above persons
(entities only):
Stephen Feinberg
--------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions):
(a) Not
(b) Applicable
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Source of Funds (See Instructions): WC
--------------------------------------------------------------------------------
5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e): Not Applicable
--------------------------------------------------------------------------------
6) Citizenship or Place of Organization: United States
--------------------------------------------------------------------------------
Number of 7) Sole Voting Power: *
------------------------------------
Shares Beneficially 8) Shared Voting Power: *
------------------------------------
Owned by
Each Reporting 9) Sole Dispositive Power: *
------------------------------------
Person With 10) Shared Dispositive Power: *
------------------------------------
--------------------------------------------------------------------------------
11) Aggregate Amount Beneficially Owned by Each Reporting Person:
1,886,221*
--------------------------------------------------------------------------------
12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions): Not Applicable
--------------------------------------------------------------------------------
13) Percent of Class Represented by Amount in Row (11): 10.7%*
--------------------------------------------------------------------------------
14) Type of Reporting Person (See Instructions): IA, IN
--------------------------------------------------------------------------------
* Cerberus Partners, L.P., a Delaware limited partnership ("Cerberus"), is
the holder of 23,425 shares of common stock (the "Shares") of Kindred
Healthcare, Inc. (the "Company"), Cerberus Institutional Partners, L.P., a
Delaware limited partnership ("Institutional"), is the holder of 351,234 Shares,
Cerberus International, Ltd., a corporation organized under the laws of the
Bahamas ("International"), is the holder of 1,009,936 Shares and various other
private investment funds (the "Funds") own in the aggregate 501,626 Shares.
Stephen Feinberg possesses sole power to vote and direct the disposition of all
securities of the Company owned by each of Cerberus, Institutional,
International and the Funds. Thus, for the purposes of Reg. Section 240.13d-3,
Stephen Feinberg is deemed to beneficially own 1,886,221 Shares, or 10.7% of
those deemed issued and outstanding. See Item 5 of this Amendment No. 4 to
Schedule 13D for further information.
Item 5. Interest in Securities of the Issuer.
------------------------------------
Based upon the Company's Annual Report on Form 10-K for the fiscal
year ended December 31, 2002, as of January 31, 2003 there were 17,648,857
Shares issued and outstanding. As of April 22, 2003, Cerberus is the holder of
23,425 Shares, Institutional is the holder of 351,234 Shares, International is
the holder of 1,009,936 Shares and the Funds in the aggregate hold 501,626
Shares. Mr. Feinberg possesses sole power to vote and direct the disposition of
all securities of the Company owned by each of Cerberus, Institutional,
International and the Funds. Thus, for the purposes of Reg. Section 240.13d-3,
Stephen Feinberg is deemed to beneficially own 1,886,221 Shares, or 10.7% of
those deemed issued and outstanding.
The following table details the transactions since the filing of the
Amendment No. 3 to Schedule 13D by Mr. Feinberg in Shares, or securities
convertible into, exercisable for or exchangeable for Shares, by Mr. Feinberg or
any other person or entity controlled by him or any person or entity for which
he possesses voting or investment control over the securities thereof (each of
which were effected in an ordinary brokerage transaction):
I. Cerberus
-----------
(Purchases)
Date Quantity Price
---- -------- -----
April 11, 2003 1,000 $11.36
April 14, 2003 100 $11.99
April 15, 2003 550 $12.12
April 16, 2003 550 $11.96
April 21, 2003 400 $12.78
April 22, 2003 125 $12.99
(Sales)
NONE
II. Institutional
-----------------
(Purchases)
Date Quantity Price
---- -------- -----
April 11, 2003 1,700 $11.36
April 14, 2003 250 $11.99
April 15, 2003 1,000 $12.12
April 16, 2003 1,100 $11.96
April 21, 2003 800 $12.78
April 22, 2003 250 $12.99
(Sales)
NONE
III. International
------------------
(Purchases)
Date Quantity Price
---- -------- -----
April 11, 2003 38,200 $11.36
April 14, 2003 5,900 $11.99
April 15, 2003 23,500 $12.12
April 16, 2003 24,450 $11.96
April 21, 2003 17,900 $12.78
April 22, 2003 5,450 $12.99
(Sales)
NONE
IV. The Funds
-------------
(Purchases)
Date Quantity Price
---- -------- -----
April 11, 2003 19,100 $11.36
April 14, 2003 2,950 $11.99
April 15, 2003 11,650 $12.12
April 16, 2003 12,100 $11.96
April 21, 2003 8,900 $12.78
April 22, 2003 2,675 $12.99
(Sales)
NONE
Signature
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
April 23, 2003
/s/ Stephen Feinberg
--------------------------------------
Stephen Feinberg, in his capacity
as the managing member of Cerberus
Associates, L.L.C., the general
partner of Cerberus Partners, L.P.,
and the investment manager for
Cerberus Institutional Partners, L.P.,
Cerberus International, Ltd. and the
Funds
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001).